Identifying Tissue-of-origin in Transplant Patients and Patients with Malignancies.

Active, not recruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

August 1, 2024

Primary Completion Date

November 1, 2027

Study Completion Date

November 12, 2027

Conditions
Malignancies
Trial Locations (1)

9112001

Hdassah Hospital, Jerusalem

All Listed Sponsors
lead

Hadassah Medical Organization

OTHER

NCT06703853 - Identifying Tissue-of-origin in Transplant Patients and Patients with Malignancies. | Biotech Hunter | Biotech Hunter